P086 Identification of a Novel Immunometabolic Target and Agonist for PLXDC2 for Amelioration of DSS Colitis Model in Mice
Saeed Abdurahiman(KU Leuven), Bram Verstockt(KU Leuven), Séverine Vermeire(KU Leuven), Fabio Cataldi(Pfizer (United States)), Rebecca Mosig
Cited by 1
Related Papers
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|779
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
|Nature Genetics|2008|523